APLS
Apellis Pharmaceuticals Inc (APLS) Investor Questions
Review Apellis Pharmaceuticals Inc (APLS) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Apellis Pharmaceuticals Inc
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 61
- Annual revenue
- $1.00B
- Annual net income
- $22.39M
- Annual free cash flow
- $45.01M
Apellis Pharmaceuticals Inc (APLS) Investor Questions research
Apellis Pharmaceuticals Inc trades under the ticker APLS. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review APLS through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.